You are here

HIV-1

ViiV Healthcare seeks USFDA approval to expand Cabenuva use for HIV-1 infected adults

Pharmaceutical Business Review

Thu, 02/25/21 - 09:50 am

ViiV Healthcare

ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato

Pharmaceutical Business Review

Fri, 08/7/20 - 10:40 am

ViiV Healthcare

ViiV Healthcare, NIH collaborate on investigational bNAb for HIV treatment

Pharmaceutical Business Review

Fri, 11/22/19 - 10:02 am

ViiV Healthcare

ViiV Submits NDA for Once-Per-Month HIV Injectable

BioSpace

Mon, 04/29/19 - 08:54 pm

ViiV Healthcare

Gilead Sciences’ Biktarvy shows high efficacy in HIV-1 study

Pharmaceutical Business Review

Thu, 10/4/18 - 09:42 am

Gilead Sciences

ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment

Yahoo

Tue, 08/16/16 - 11:14 am

ViiV Healthcare

Gilead's HIV-1 Drug Wins Approval in Europe

Motley Fool

Tue, 11/19/13 - 07:37 am

Gilead Sciences

ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1

Yahoo

Fri, 09/13/13 - 08:30 am

ViiV Healthcare